« Small numbers and scams | Main | The old is the new new thing »


Feed You can follow this conversation by subscribing to the comment feed for this post.


Please clarify your last sentence. It would seem that GSK is pretty hosed.


Jay: GSK's spokesman is "worried" that the new studies do not have the same credibility as their own clinical trials. I'm sure he/she is very worried about the prospect of Avandia! Sorry - the tongue in cheek doesn't translate well on line.


You should probably qualify your statement about sample sizes; a meta-analysis across studies involving 200k people total is not the same as one study of 200k people (I guess in theory they could be equivalent, if each study was conducted exactly the same - but that's not really a "meta-analysis").

The takeaway is that large sample sizes doesn't (always) trump design considerations.


J: agree that larger sample size is not always better. However, in this case, I believe that the spokesman is setting up a straw man. There are practical limitations to how large the sample size could be for a clinical trial. If multiple trials are available, a meta-analysis can help pool the information. It's by no means foolproof but I'd believe the pooled analysis of 56 trials more than the one trial GSK deems to be "well-designed".

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Your Information

(Name is required. Email address will not be displayed with the comment.)

Marketing and advertising analytics expert. Author and Speaker. Currently at Columbia. See my full bio.

Spring 2015 Courses (New York)

Jan 26: Business Analytics & Data Visualization (14 weeks) Info

Feb 23: Statistics for Management (10 weeks) Info

Mar 28: Careers in Business Analytics & Data Science (one-day seminar) Register

Apr 7: The Art of Data Visualization Workshop (6 weeks) Register

Next Events

Sep: 28 Data Visualization New York Meetup, New York, NY

Oct: 5 Andrew Gelman’s Statistical Communications class, Columbia University

Oct: 13 AQR ProSeminar, NYU Sociology

Oct: 22 Leading Business Change Through Analytics, Columbia Business School

Oct: 30 Ray Vella’s Designing Infographics class, NYU

Past Events

See here

Junk Charts Blog

Link to junkcharts

Graphics design by Amanda Lee


  • only in Big Data